1. Clinical Pathology Quality Dashboard April 2009

2. Clinical Pathology Quality Dashboard Inpatient Phlebotomy First AM Blood Draws

3. Clinical Pathology Quality Dashboard Inpatient Phlebotomy First AM Blood Test Results: PT/PTT, CBCP, and Comprehensive Panel

4. Inpatient Phlebotomy Draws Fiscal Year 2009 Clinical Pathology Quality Dashboard

5. Turnaround Times

6. Clinical Pathology Quality Dashboard Molecular Diagnostics Laboratory

7. Clinical Pathology Quality Dashboard Chemistry In-Lab Turnaround Times

8. Clinical Pathology Quality Dashboard New Clinical Assays Added in Last Year Yeast identification system: (Vitek II automated) Yeast antimicrobial susceptibility: (Vitek II automated) EBV viral load HIV-1 quantification (COBAS Ampli Prep – COBAS Taqman) (includes extraction, amplification) MRSA surveillance VRE surveillance C.difficile surveillance BCR/ABL1 Kinase Mutation Analysis (Sequencing) Human Erythrocyte Antigen Genotyping (Microarray analysis) IGH/BCL2 Translocation Detection (Real-time PCR) JAK2 V167F Mutation Detection (Allele-specific PCR) KIT D816V Mutation Detection (Allele-specific PCR) KIT Mutation Detection for GIST KIT Mutation Detection of Melanoma NPM1 Mutation Detection (PCR w/ capillary electrophoresis detection) Microsatellite instability analysis PML/RARA t(15;17) Translocation Detection (Real-time PCR) Urovysion – FISH, Bladder Cancer Detection HER2 Amplification – FISH, Breast Cancer UGT1A1 Promoter Genotyping K-Ras Mutation Detection 1,25 Dihydroxy vitamin D Sensitive beta-2 transferrin assay

9. UMHS Blood Product Utilization Clinical Pathology Quality Dashboard

10. CAP Proficiency Testing 3 rd Quarter FY 2009 Clinical Pathology 24 = Number of Challenges 100% = Satisfactory Results Anatomic Pathology 0 = Number of Challenges N/A = Satisfactory Results Department Total 24 = Number of Challenges 100% = Satisfactory Results

11. Clinical Pathology Quality Dashboard CP Financial Measures

12. Discontinue Cancer Center Hematology Lab (move to Main Lab) – Will Finn, MD, lead Improvement of Critical Value Callback process – Brenda Schroeder, lead Impact of Earlier AM Blood Draw in UH – OMS 490 students and Holly Eliot, leads Improvement of Communication with Patient Care Units – Beverly Smith and Brenda Schroeder, leads Customer Service Initiative – Beverly Smith, lead Lab Formulary Committee – Office of Clinical Affairs, FGP, Pathology Lean Process Improvement Projects – many! Laboratory Safety focus – Brenda Schroeder, lead Improvement of Blood Draw Wait Times - Cancer Center - Taubman 2 - Taubman 3 Creation of Blood Product Utilization Lean Team – Tim Laing, MD, (OCA), lead Clinical Pathology Quality Dashboard Clinical Laboratory Operations Initiatives

13. Clostridium difficile toxin screening algorithm – 1/09 On-demand unit-specific antibiograms – 2/09 Expedited (rules – based) release of ANCs (absolute neutrophil counts) – 2/09 Integrated hematopathology reports – 2/09 Troponin point-of-care (ED) – 3/09 Clinical Pathology Quality Dashboard Clinical Laboratory Service Enhancements

14. Kudos Clinical Pathology Quality Dashboard Thank you to the Phlebotomy Team and Harry Neusius; Julius Alexander and John Hamilton (Pathology Informatics); Tom Morrow, Brenda Schroeder, John Perrin, and Holly Eliot (Pathology Administration) for their excellent work with Ross Business School OMS 490 students – in the development of a new tool to better match early AM blood drawing resources with service demand. Thank you to the Chemistry Lab and the Emergency Department Point-of-Care Lab for implementation of rapid troponin assay in the ED. See the marked improvement in ED Cardiac Marker TAT! Congratulations to Drs. Lloyd Stoolman (Pathology) and Matthew Velkey (Cell and Developmental Biology) who received one of only five University of Michigan Provost’s 2009 Teaching Innovation Prizes – for the project entitled “Virtual Microscopy for Life Sciences Education”! More than 100 projects were nominated. Please see the Pathology Website for a link to a more detailed description of this outstanding innovation.